Literature DB >> 12969225

Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.

Hideo Kurokawa1, Shinobu Matsumoto, Tomoyuki Murata, Yoshihiro Yamashita, Taiki Tomoyose, Min Zhang, Hiroshi Fukuyama, Tetsu Takahashi.   

Abstract

BACKGROUND: Leukoplakia is an oral pre-cancerous lesion that sometimes develops into squamous cell carcinoma. Therefore, leukoplakia with epithelial dysplasia is useful for studying carcinogenesis at the cellular level. The purpose of this study was to evaluate a potential association between the loss of syndecan-1 expression and the expression of p53 protein and Ki-67 antigen, and to identify reliable markers for predicting malignant changes in oral leukoplakia with epithelial dysplasia.
METHODS: Changes in the expression of syndecan-1, p53, and Ki-67 were examined immunohistochemically in 43 cases of oral leukoplakia with or without epithelial dysplasia. The subjects were categorized as: none, 13 cases; mild dysplasia, 5 cases; moderate dysplasia, 17 cases; and severe dysplasia, 8 cases. The expression of these molecules in normal oral epithelia (22 cases) was also investigated.
RESULTS: Strong syndecan-1 expression was observed on the surface of keratinocytes in normal epithelium. Immunopositivity was lost gradually as the extent of epithelial dysplasia increased. In normal epithelium, p53 and Ki-67 appeared mainly in the basal cell layer, while they were more widely distributed in leukoplakia. Specifically, significant changes were observed in the labeling index of p53 and Ki-67 in leukoplakia as epithelial dysplasia progressed from mild to moderate or severe.
CONCLUSION: Our results reveal that overexpression of p53 protein and Ki-67 antigen, and down-regulation of syndecan-1 expression in the lower part of the epithelium, are associated with dysplastic changes. Therefore, the down-regulation of syndecan-1 expression may be the most important reliable marker for dysplastic changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969225     DOI: 10.1034/j.1600-0714.2003.00117.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  17 in total

1.  Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.

Authors:  Bianca C Bianco; Fernanda M Scotti; Daniella S C Vieira; Michelle T Biz; Renata G Castro; Filipe Modolo
Journal:  Int J Exp Pathol       Date:  2015-10-30       Impact factor: 1.925

2.  Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.

Authors:  Kim Vaiphei; Neeraj Kumari; Saroj-Kant Sinha; Usha Dutta; Birinder Nagi; Kusum Joshi; Kartar Singh
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  The expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinoma.

Authors:  Hyunjin Kim; Dong Soon Choi; Suk-Joon Chang; Jae Ho Han; Churl K Min; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

4.  Characteristics of benign lymphoadenosis of oral mucosa.

Authors:  Shu-Xia Li; Shi-Feng Yu; Kai-Hua Sun
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

5.  Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasia.

Authors:  Keisuke Sawada; Shuji Momose; Ryutaro Kawano; Masakazu Kohda; Tarou Irié; Kenji Mishima; Takahiro Kaneko; Norio Horie; Yasushi Okazaki; Morihiro Higashi; Jun-Ichi Tamaru
Journal:  Mod Pathol       Date:  2021-08-17       Impact factor: 7.842

Review 6.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

7.  Proliferation and apoptosis markers in oral submucous fibrosis.

Authors:  K Ranganathan; R Kavitha
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

8.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

9.  Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development.

Authors:  D R Camidge; M N Pemberton; J W Growcott; D Johnstone; P J Laud; J R Foster; K J Randall; A M Hughes
Journal:  Br J Cancer       Date:  2005-07-25       Impact factor: 7.640

10.  Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study.

Authors:  Alper Sinanoglu; Merva Soluk-Tekkesin; Vakur Olgac
Journal:  J Oral Maxillofac Res       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.